Market Research Logo

Nuclear Medicine/Radiopharmaceuticals Market by Type (Diagnostic (SPECT (Technetium), PET (F-18)), Therapeutic (Beta Emitters (I-131), Alpha Emitters, Brachytherapy(Y-90))), Application (Oncology, Thyroid, Cardiology) - Global Forecasts to 2023

Nuclear Medicine/Radiopharmaceuticals Market by Type (Diagnostic (SPECT (Technetium), PET (F-18)), Therapeutic (Beta Emitters (I-131), Alpha Emitters, Brachytherapy(Y-90))), Application (Oncology, Thyroid, Cardiology) - Global Forecasts to 2023

“The nuclear medicine market is projected to grow at a CAGR of 5.9%”
The nuclear medicine market is projected to reach USD 5.26 billion by 2023 from USD 3.95 billion in 2018. Factors such as the growing incidence and prevalence of cancer and cardiac ailments and initiatives to lessen the demand-supply gap of Mo-99, are driving market growth. However, the short half-life of radiopharmaceuticals, hospital budget cuts, and high equipment prices are likely to restrain market growth.

“The F-18 segment to dominate the PET nuclear medicine market during the forecast period”
Based on type, the nuclear medicine market is segmented into diagnostic radiopharmaceuticals and therapeutic radiopharmaceuticals. The diagnostic radiopharmaceuticals have been segmented into SPECT and PET radiopharmaceuticals. PET radiopharmaceuticals have been further segmented into F-18, Ru-82, and other PET isotopes. In 2017, the F-18 segment accounted for the largest share of the nuclear medicine PET radiopharmaceuticals market. F-18 is the most commonly used PET radioisotope owing to its higher half-life (110 minutes) compared to other radioisotopes. F-18 is estimated to account for 98% of the total PET radioisotopes market.

“The thyroid application segment is expected to be the fastest growing SPECT applications segment”
The major application areas of SPECT nuclear medicine include cardiology, lymphoma, thyroid, neurology and others (prostate cancer diagnosis, bone scans, and white cell scans). The thyroid applications segment is expected to register the highest CAGR during the forecast period. Growth in this application segment is mainly driven by the rising demand for combinational SPECT/CT therapy owing to its enhanced imaging abilities. Moreover, with growth in the number of thyroid cancer cases, the use of radiopharmaceuticals for diagnosis of thyroid disorders is expected to increase in the next five years.

“In 2018, North America is expected to dominate the nuclear medicine market”
The nuclear medicine market is divided into four major regions— North America, Europe, Asia Pacific, and the Rest of the World. North America accounted for the largest share of the nuclear medicine market. The major factors contributing to the large share of this segment include the development of novel technologies for radioisotope production, government support, and company initiatives in the region.

Asia Pacific is expected to register the highest CAGR during the forecast period. The major factors driving the growth of this regional segment include research initiatives in Japan and the rising installations of PET scanners in India and China.

Break of primary participants was as mentioned below:
By Company Type - Tier 1: 54%, Tier 2: 34%, and Tier 3: 12%
By Designation - C-level: 31%, Director Level: 19%, Others: 50%
By Region - North America: 46%, Europe: 25%, Asia Pacific: 18%, RoW: 11%
The major market players in the nuclear medicine market include Cardinal Health (US), GE Healthcare (US), and Curium (France).

Research Coverage:
The report analyzes the market and aims at estimating the size and the future growth potential of this market based on various segments such as type, application, procedural volume, and region. The report also includes the competitive landscape of the key players along with their company profiles, product offerings, recent developments, and key market strategies.

Reasons to Buy the Report
The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them garner a greater market share. Firms purchasing the report could use any one or a combination of the below-mentioned strategies.

This report provides insights on the following pointers:
Market Penetration: Comprehensive information on products and services offered by the top players in the global nuclear medicine market
Product Development/Innovation: Detailed insights on upcoming technologies, research and development activities, and product launches in the nuclear medicine market
Market Development: Comprehensive information about the lucrative emerging markets by type, end user, and region
Market Diversification: Exhaustive information about new products or product enhancements, growing geographies, recent developments, and investments in the global nuclear medicine market
Competitive Assessment: In-depth assessment of market shares, growth strategies, and products of leading players in the global market


  • INTRODUCTION
    • OBJECTIVES OF STUDY
    • MARKET DEFINITION
    • MARKET SCOPE
      • MARKETS COVERED
      • YEARS CONSIDERED FOR THE STUDY
    • CURRENCY
    • LIMITATIONS
    • STAKEHOLDERS
  • RESEARCH METHODOLOGY
    • RESEARCH METHODOLOGY STEPS
    • SECONDARY AND PRIMARY RESEARCH METHODOLOGY
      • SECONDARY RESEARCH
      • PRIMARY RESEARCH
    • MARKET SIZE ESTIMATION METHODOLOGY
    • MARKET DATA VALIDATION AND TRIANGULATION
    • ASSUMPTIONS FOR THE STUDY
  • EXECUTIVE SUMMARY
  • PREMIUM INSIGHTS
    • NUCLEAR MEDICINE: MARKET OVERVIEW
    • GEOGRAPHIC ANALYSIS: NUCLEAR MEDICINE MARKET FOR PET APPLICATIONS, BY TYPE (2017)
    • NUCLEAR MEDICINE MARKET SHARE, BY TYPE, 2018 VS. 2023
    • GEOGRAPHICAL SNAPSHOT OF THE NUCLEAR MEDICINE MARKET
  • MARKET OVERVIEW
    • INTRODUCTION
      • MARKET DYNAMICS
      • DRIVERS
        • Table NEW REACTORS EXPECTED TO OPEN DURING THE FORECAST PERIOD
      • RESTRAINTS
      • OPPORTUNITIES
      • CHALLENGES
  • NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET, BY TYPE
    • INTRODUCTION
      • Table NUCLEAR MEDICINE MARKET, BY TYPE, 2016–2023 (USD MILLION)
    • DIAGNOSTIC NUCLEAR MEDICINE
      • Table DIAGNOSTIC NUCLEAR MEDICINE MARKET, BY TYPE, 2016–2023 (USD MILLION)
      • Table DIAGNOSTIC NUCLEAR MEDICINE MARKET, BY REGION, 2016–2023 (USD MILLION)
      • Table NORTH AMERICA: DIAGNOSTIC NUCLEAR MEDICINE MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
      • Table EUROPE: DIAGNOSTIC NUCLEAR MEDICINE MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
      • SPECT RADIOPHARMACEUTICALS
        • Table SPECT RADIOPHARMACEUTICALS MARKET, BY TYPE, 2016–2023 (USD MILLION)
        • Table SPECT RADIOPHARMACEUTICALS MARKET, BY REGION, 2016–2023 (USD MILLION)
        • Table NORTH AMERICA: SPECT RADIOPHARMACEUTICALS MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
        • Table EUROPE: SPECT RADIOPHARMACEUTICALS MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
        • Table TC-99M MARKET, BY REGION, 2016–2023 (USD MILLION)
        • Table NORTH AMERICA: TC-99M MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
        • Table EUROPE: TC-99M MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
        • Table TL-201 MARKET, BY REGION, 2016–2023 (USD MILLION)
        • Table NORTH AMERICA: TL-201 MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
        • Table EUROPE: TL-201 MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
        • Table GA-67 MARKET, BY REGION, 2016–2023 (USD MILLION)
        • Table NORTH AMERICA: GA-67 MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
        • Table EUROPE: GA-67 MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
        • Table I-123 MARKET, BY REGION, 2016–2023 (USD MILLION)
        • Table NORTH AMERICA: I-123 MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
        • Table EUROPE: I-123 MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
        • Table OTHER SPECT ISOTOPES MARKET, BY REGION, 2016–2023 (USD MILLION)
        • Table NORTH AMERICA: OTHER SPECT ISOTOPES MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
        • Table EUROPE: OTHER SPECT ISOTOPES MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
      • PET RADIOPHARMACEUTICALS
        • Table PET RADIOPHARMACEUTICALS MARKET, BY TYPE, 2016–2023 (USD MILLION)
        • Table PET RADIOPHARMACEUTICALS MARKET, BY REGION, 2016–2023 (USD MILLION)
        • Table NORTH AMERICA: PET RADIOPHARMACEUTICALS MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
        • Table EUROPE: PET RADIOPHARMACEUTICALS MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
        • Table F-18 MARKET, BY REGION, 2016–2023 (USD MILLION)
        • Table NORTH AMERICA: F-18 MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
        • Table EUROPE: F-18 MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
        • Table RU-82 MARKET, BY REGION, 2016–2023 (USD MILLION)
        • Table NORTH AMERICA: RU-82 MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
        • Table EUROPE: RU-82 MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
        • Table OTHER PET ISOTOPES MARKET, BY REGION, 2016–2023 (USD MILLION)
        • Table NORTH AMERICA: OTHER PET ISOTOPES MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
        • Table EUROPE: OTHER PET ISOTOPES MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
    • THERAPEUTIC NUCLEAR MEDICINE
      • Table THERAPEUTIC NUCLEAR MEDICINE MARKET, BY TYPE, 2016–2023 (USD MILLION)
      • Table THERAPEUTIC NUCLEAR MEDICINE MARKET, BY REGION, 2016–2023 (USD MILLION)
      • Table NORTH AMERICA: THERAPEUTIC NUCLEAR MEDICINE MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
      • Table EUROPE: THERAPEUTIC NUCLEAR MEDICINE MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
      • ALPHA EMITTERS
        • Table RA-223 MARKET, BY REGION, 2016–2023 (USD MILLION)
        • Table NORTH AMERICA: RA-223 MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
        • Table EUROPE: RA-223 MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
      • BETA EMITTERS
        • Table BETA EMITTERS MARKET, BY TYPE, 2016–2023 (USD MILLION)
        • Table BETA EMITTERS MARKET, BY REGION, 2016–2023 (USD MILLION)
        • Table NORTH AMERICA: BETA EMITTERS MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
        • Table EUROPE: BETA EMITTERS MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
        • Table I-131 MARKET, BY REGION, 2016–2023 (USD MILLION)
        • Table NORTH AMERICA: I-131 MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
        • Table EUROPE: I-131 MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
        • Table Y-90 MARKET, BY REGION, 2016–2023 (USD MILLION)
        • Table NORTH AMERICA: Y-90 MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
        • Table EUROPE: Y-90 MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
        • Table SM-153 MARKET, BY REGION, 2016–2023 (USD MILLION)
        • Table NORTH AMERICA: SM-153 MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
        • Table EUROPE: SM-153 MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
        • Table RE-186 MARKET, BY REGION, 2016–2023 (USD MILLION)
        • Table NORTH AMERICA: RE-186 MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
        • Table EUROPE: RE-186 MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
        • Table LU-177 MARKET, BY REGION, 2016–2023 (USD MILLION)
        • Table NORTH AMERICA: LU-177 MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
        • Table EUROPE: LU-177 MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
        • Table OTHER BETA EMITTERS MARKET, BY REGION, 2016–2023 (USD MILLION)
        • Table NORTH AMERICA: OTHER BETA EMITTERS MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
        • Table EUROPE: OTHER BETA EMITTERS MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
      • BRACHYTHERAPY ISOTOPES
        • Table BRACHYTHERAPY ISOTOPES MARKET, BY TYPE, 2016–2023 (USD MILLION)
        • Table BRACHYTHERAPY ISOTOPES MARKET, BY REGION, 2016–2023 (USD MILLION)
        • Table NORTH AMERICA: BRACHYTHERAPY ISOTOPES MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
        • Table EUROPE: BRACHYTHERAPY ISOTOPES MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
        • Table I-125 MARKET, BY REGION, 2016–2023 (USD MILLION)
        • Table NORTH AMERICA: IODINE-125 MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
        • Table EUROPE: IODINE-125 MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
        • Table IR-192 MARKET, BY REGION, 2016–2023 (USD MILLION)
        • Table NORTH AMERICA: IR-192 MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
        • Table EUROPE: IR-192 MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
        • Table PD-103 MARKET, BY REGION, 2016–2023 (USD MILLION)
        • Table NORTH AMERICA: PD-103 MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
        • Table EUROPE: PD-103 MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
        • Table CS-131 MARKET, BY REGION, 2016–2023 (USD MILLION)
        • Table NORTH AMERICA: CS-131 MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
        • Table EUROPE: CS-131 MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
        • Table OTHER BRACHYTHERAPY ISOTOPES MARKET, BY REGION, 2016–2023 (USD MILLION)
        • Table NORTH AMERICA: OTHER BRACHYTHERAPY ISOTOPES MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
        • Table EUROPE: OTHER BRACHYTHERAPY ISOTOPES MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
  • NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET, BY APPLICATION
    • INTRODUCTION
    • DIAGNOSTIC APPLICATIONS
      • SPECT APPLICATIONS
        • Table SPECT APPLICATIONS MARKET, BY TYPE, 2016–2023 (USD MILLION)
        • Table SPECT APPLICATIONS MARKET, BY REGION, 2016–2023 (USD MILLION)
        • Table CARDIOLOGY APPLICATIONS MARKET, BY REGION, 2016–2023 (USD MILLION)
        • Table LYMPHOMA APPLICATIONS MARKET, BY REGION, 2016–2023 (USD MILLION)
        • Table NEUROLOGY APPLICATIONS MARKET, BY REGION, 2016–2023 (USD MILLION)
        • Table THYROID APPLICATIONS MARKET, BY REGION, 2016–2023 (USD MILLION)
        • Table OTHER SPECT APPLICATIONS MARKET, BY REGION, 2016–2023 (USD MILLION)
      • PET APPLICATIONS
        • Table PET APPLICATIONS MARKET, BY TYPE, 2016–2023 (USD MILLION)
        • Table PET APPLICATIONS MARKET, BY REGION, 2016–2023 (USD MILLION)
        • Table ONCOLOGY APPLICATIONS MARKET, BY REGION, 2016–2023 (USD MILLION)
        • Table CARDIOLOGY APPLICATIONS MARKET, BY REGION, 2016–2023 (USD MILLION)
        • Table NEUROLOGY APPLICATIONS MARKET, BY REGION, 2016–2023 (USD MILLION)
        • Table OTHER PET APPLICATIONS MARKET, BY REGION, 2016–2023 (USD MILLION)
    • THERAPEUTIC APPLICATIONS
      • Table THERAPEUTIC APPLICATIONS MARKET, BY TYPE, 2016–2023 (USD MILLION)
      • Table THERAPEUTIC APPLICATIONS MARKET, BY REGION, 2016–2023 (USD MILLION)
      • THYROID
        • Table THYROID APPLICATIONS MARKET, BY REGION, 2016–2023 (USD MILLION)
      • BONE METASTASIS
        • Table BONE METASTASIS APPLICATIONS MARKET, BY REGION, 2016–2023 (USD MILLION)
      • LYMPHOMA
        • Table LYMPHOMA APPLICATIONS MARKET, BY REGION, 2016–2023 (USD MILLION)
      • ENDOCRINE TUMORS
        • Table ENDOCRINE APPLICATIONS MARKET, BY REGION, 2016–2023 (USD MILLION)
      • OTHER THERAPEUTIC APPLICATIONS
        • Table OTHER THERAPEUTIC APPLICATIONS MARKET, BY REGION, 2016–2023 (USD MILLION)
  • NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET, BY PROCEDURAL VOLUME
    • INTRODUCTION
      • Table NUCLEAR MEDICINE PROCEDURES MARKET, BY TYPE, 2016–2023 (THOUSAND PROCEDURES)
      • Table NUCLEAR MEDICINE PROCEDURES MARKET, BY REGION, 2016–2023 (THOUSAND PROCEDURES)
    • DIAGNOSTIC PROCEDURES
      • Table DIAGNOSTIC PROCEDURES MARKET, BY TYPE, 2016–2023 (THOUSAND PROCEDURES)
      • Table DIAGNOSTIC PROCEDURES MARKET, BY REGION, 2016–2023 (THOUSAND PROCEDURES)
      • SPECT RADIOPHARMACEUTICALS
        • Table SPECT RADIOPHARMACEUTICALS MARKET, BY TYPE, 2016–2023 (THOUSAND PROCEDURES)
        • Table SPECT RADIOPHARMACEUTICALS MARKET, BY TYPE, BY REGION, 2016–2023 (THOUSAND PROCEDURES)
      • PET RADIOPHARMACEUTICALS
        • Table PET RADIOPHARMACEUTICALS MARKET, BY TYPE, 2016–2023 (THOUSAND PROCEDURES)
        • Table PET RADIOPHARMACEUTICALS MARKET, BY TYPE, 2016–2023 (THOUSAND PROCEDURES)
    • THERAPEUTIC PROCEDURES
      • Table THERAPEUTIC PROCEDURES MARKET, BY TYPE, 2016–2023 (THOUSAND PROCEDURES)
      • Table THERAPEUTIC PROCEDURES MARKET, BY REGION, 2016–2023 (THOUSAND PROCEDURES)
      • BETA EMITTERS
        • Table BETA EMITTERS MARKET, BY TYPE, 2016–2023 (THOUSAND PROCEDURES)
        • Table BETA EMITTERS MARKET, BY REGION, 2016–2023 (THOUSAND PROCEDURES)
      • ALPHA EMITTERS
        • Table ALPHA EMITTERS MARKET, BY REGION, 2016–2023 (THOUSAND PROCEDURES)
      • BRACHYTHERAPY ISOTOPES
        • Table BRACHYTHERAPY ISOTOPES MARKET, BY TYPE, 2016–2023 (THOUSAND PROCEDURES)
        • Table BRACHYTHERAPY ISOTOPES MARKET, BY REGION, 2016–2023 (THOUSAND PROCEDURES)
  • NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET, BY REGION
    • INTRODUCTION
      • Table NUCLEAR MEDICINE MARKET, BY REGION, 2016–2023 (USD MILLION)
    • NORTH AMERICA
      • Table NORTH AMERICA: NUCLEAR MEDICINE MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
      • Table NORTH AMERICA: NUCLEAR MEDICINE MARKET, BY TYPE, 2016–2023 (USD MILLION)
      • Table NORTH AMERICA: DIAGNOSTIC NUCLEAR MEDICINE MARKET, BY TYPE, 2016–2023 (USD MILLION)
      • Table NORTH AMERICA: SPECT RADIOPHARMACEUTICALS MARKET, BY TYPE, 2016–2023 (USD MILLION)
      • Table NORTH AMERICA: SPECT RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2016–2023 (USD MILLION)
      • Table NORTH AMERICA: PET RADIOPHARMACEUTICALS MARKET, BY TYPE, 2016–2023 (USD MILLION)
      • Table NORTH AMERICA: PET RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2016–2023 (USD MILLION)
      • Table NORTH AMERICA: THERAPEUTIC NUCLEAR MEDICINE MARKET, BY TYPE, 2016–2023 (USD MILLION)
      • Table NORTH AMERICA: BETA EMITTERS MARKET, BY TYPE, 2016–2023 (USD MILLION)
      • Table NORTH AMERICA: BRACHYTHERAPY ISOTOPES MARKET, BY TYPE, 2016–2023 (USD MILLION)
      • Table NORTH AMERICA: THERAPEUTIC NUCLEAR MEDICINE MARKET, BY APPLICATION, 2016–2023 (USD MILLION)
      • US
        • Table US: NUCLEAR MEDICINE MARKET, BY TYPE, 2016–2023 (USD MILLION)
        • Table US: DIAGNOSTIC NUCLEAR MEDICINE MARKET, BY TYPE, 2016–2023 (USD MILLION)
        • Table US: SPECT RADIOPHARMACEUTICALS MARKET, BY TYPE, 2016–2023 (USD MILLION)
        • Table US: SPECT RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2016–2023 (USD MILLION)
        • Table US: PET RADIOPHARMACEUTICALS MARKET, BY TYPE, 2016–2023 (USD MILLION)
        • Table US: PET RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2016–2023 (USD MILLION)
        • Table US: THERAPEUTIC NUCLEAR MEDICINE MARKET, BY TYPE, 2016–2023 (USD MILLION)
        • Table US: BETA EMITTERS MARKET, BY TYPE, 2016–2023 (USD MILLION)
        • Table US: BRACHYTHERAPY ISOTOPES MARKET, BY TYPE, 2016–2023 (USD MILLION)
        • Table US: THERAPEUTIC NUCLEAR MEDICINE MARKET, BY APPLICATION, 2016–2023 (USD MILLION)
      • CANADA
        • Table CANADA: NUCLEAR MEDICINE MARKET, BY TYPE, 2016–2023 (USD MILLION)
        • Table CANADA: DIAGNOSTIC NUCLEAR MEDICINE MARKET, BY TYPE, 2016–2023 (USD MILLION)
        • Table CANADA: SPECT RADIOPHARMACEUTICALS MARKET, BY TYPE, 2016–2023 (USD MILLION)
        • Table CANADA: SPECT RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2016–2023 (USD MILLION)
        • Table CANADA: PET RADIOPHARMACEUTICALS MARKET, BY TYPE, 2016–2023 (USD MILLION)
        • Table CANADA: PET RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2016–2023 (USD MILLION)
        • Table CANADA: THERAPEUTIC NUCLEAR MEDICINE MARKET, BY TYPE, 2016–2023 (USD MILLION)
        • Table CANADA: BETA EMITTERS MARKET, BY TYPE, 2016–2023 (USD MILLION)
        • Table CANADA: BRACHYTHERAPY ISOTOPES MARKET, BY TYPE, 2016–2023 (USD MILLION)
        • Table CANADA: THERAPEUTIC NUCLEAR MEDICINE MARKET, BY APPLICATION, 2016–2023 (USD MILLION)
    • EUROPE
      • Table EUROPE: NUCLEAR MEDICINE MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
      • Table EUROPE: NUCLEAR MEDICINE MARKET, BY TYPE, 2016–2023 (USD MILLION)
      • Table EUROPE: DIAGNOSTIC NUCLEAR MEDICINE MARKET, BY TYPE, 2016–2023 (USD MILLION)
      • Table EUROPE: SPECT RADIOPHARMACEUTICALS MARKET, BY TYPE, 2016–2023 (USD MILLION)
      • Table EUROPE: SPECT RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2016–2023 (USD MILLION)
      • Table EUROPE: PET RADIOPHARMACEUTICALS MARKET, BY TYPE, 2016–2023 (USD MILLION)
      • Table EUROPE: PET RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2016–2023 (USD MILLION)
      • Table EUROPE: THERAPEUTIC NUCLEAR MEDICINE MARKET, BY TYPE, 2016–2023 (USD MILLION)
      • Table EUROPE: BETA EMITTERS MARKET, BY TYPE, 2016–2023 (USD MILLION)
      • Table EUROPE: BRACHYTHERAPY ISOTOPES MARKET, BY TYPE, 2016–2023 (USD MILLION)
      • Table EUROPE: THERAPEUTIC NUCLEAR MEDICINE MARKET, BY APPLICATION, 2016–2023 (USD MILLION)
      • GERMANY
        • Table GERMANY: NUCLEAR MEDICINE MARKET, BY TYPE, 2016–2023 (USD MILLION)
        • Table GERMANY: DIAGNOSTIC NUCLEAR MEDICINE MARKET, BY TYPE, 2016–2023 (USD MILLION)
        • Table GERMANY: SPECT RADIOPHARMACEUTICALS MARKET, BY TYPE, 2016–2023 (USD MILLION)
        • Table GERMANY: SPECT RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2016–2023 (USD MILLION)
        • Table GERMANY: PET RADIOPHARMACEUTICALS MARKET, BY TYPE, 2016–2023 (USD MILLION)
        • Table GERMANY: PET RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2016–2023 (USD MILLION)
        • Table GERMANY: THERAPEUTIC NUCLEAR MEDICINE MARKET, BY TYPE, 2016–2023 (USD MILLION)
        • Table GERMANY: BETA EMITTERS MARKET, BY TYPE, 2016–2023 (USD MILLION)
        • Table GERMANY: BRACHYTHERAPY ISOTOPES MARKET, BY TYPE, 2016–2023 (USD MILLION)
        • Table GERMANY: THERAPEUTIC NUCLEAR MEDICINE MARKET, BY APPLICATION, 2016–2023 (USD MILLION)
      • FRANCE
        • Table FRANCE: NUCLEAR MEDICINE MARKET, BY TYPE, 2016–2023 (USD MILLION)
        • Table FRANCE: DIAGNOSTIC NUCLEAR MEDICINE MARKET, BY TYPE, 2016–2023 (USD MILLION)
        • Table FRANCE: SPECT RADIOPHARMACEUTICALS MARKET, BY TYPE, 2016–2023 (USD MILLION)
        • Table FRANCE: SPECT RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2016–2023 (USD MILLION)
        • Table FRANCE: PET RADIOPHARMACEUTICALS MARKET, BY TYPE, 2016–2023 (USD MILLION)
        • Table FRANCE: PET RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2016–2023 (USD MILLION)
        • Table FRANCE: THERAPEUTIC NUCLEAR MEDICINE MARKET, BY TYPE, 2016–2023 (USD MILLION)
        • Table FRANCE: BETA EMITTERS MARKET, BY TYPE, 2016–2023 (USD MILLION)
        • Table FRANCE: BRACHYTHERAPY ISOTOPES MARKET, BY TYPE, 2016–2023 (USD MILLION)
        • Table FRANCE: THERAPEUTIC NUCLEAR MEDICINE MARKET, BY APPLICATION, 2016–2023 (USD MILLION)
      • UK
        • Table UK: NUCLEAR MEDICINE MARKET, BY TYPE, 2016–2023 (USD MILLION)
        • Table UK: DIAGNOSTIC NUCLEAR MEDICINE MARKET, BY TYPE, 2016–2023 (USD MILLION)
        • Table UK: SPECT RADIOPHARMACEUTICALS MARKET, BY TYPE, 2016–2023 (USD MILLION)
        • Table UK: SPECT RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2016–2023 (USD MILLION)
        • Table UK: PET RADIOPHARMACEUTICALS MARKET, BY TYPE, 2016–2023 (USD MILLION)
        • Table UK: PET RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2016–2023 (USD MILLION)
        • Table UK: THERAPEUTIC NUCLEAR MEDICINE MARKET, BY TYPE, 2016–2023 (USD MILLION)
        • Table UK: BETA EMITTERS MARKET, BY TYPE, 2016–2023 (USD MILLION)
        • Table UK: BRACHYTHERAPY ISOTOPES MARKET, BY TYPE, 2016–2023 (USD MILLION)
        • Table UK: THERAPEUTIC NUCLEAR MEDICINE MARKET, BY APPLICATION, 2016–2023 (USD MILLION)
      • ITALY
        • Table ITALY: NUCLEAR MEDICINE MARKET, BY TYPE, 2016–2023 (USD MILLION)
        • Table ITALY: DIAGNOSTIC NUCLEAR MEDICINE MARKET, BY TYPE, 2016–2023 (USD MILLION)
        • Table ITALY: SPECT RADIOPHARMACEUTICALS MARKET, BY TYPE, 2016–2023 (USD MILLION)
        • Table ITALY: SPECT RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2016–2023 (USD MILLION)
        • Table ITALY: PET RADIOPHARMACEUTICALS MARKET, BY TYPE, 2016–2023 (USD MILLION)
        • Table ITALY: PET RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2016–2023 (USD MILLION)
        • Table ITALY: THERAPEUTIC NUCLEAR MEDICINE MARKET, BY TYPE, 2016–2023 (USD MILLION)
        • Table ITALY: BETA EMITTERS MARKET, BY TYPE, 2016–2023 (USD MILLION)
        • Table ITALY: BRACHYTHERAPY ISOTOPES MARKET, BY TYPE, 2016–2023 (USD MILLION)
        • Table ITALY: THERAPEUTIC NUCLEAR MEDICINE MARKET, BY APPLICATION, 2016–2023 (USD MILLION)
      • SPAIN
        • Table SPAIN: NUCLEAR MEDICINE MARKET, BY TYPE, 2016–2023 (USD MILLION)
        • Table SPAIN: DIAGNOSTIC NUCLEAR MEDICINE MARKET, BY TYPE, 2016–2023 (USD MILLION)
        • Table SPAIN: SPECT RADIOPHARMACEUTICALS MARKET, BY TYPE, 2016–2023 (USD MILLION)
        • Table SPAIN: SPECT RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2016–2023 (USD MILLION)
        • Table SPAIN: PET RADIOPHARMACEUTICALS MARKET, BY TYPE, 2016–2023 (USD MILLION)
        • Table SPAIN: PET RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2016–2023 (USD MILLION)
        • Table SPAIN: THERAPEUTIC NUCLEAR MEDICINE MARKET, BY TYPE, 2016–2023 (USD MILLION)
        • Table SPAIN: BETA EMITTERS MARKET, BY TYPE, 2016–2023 (USD MILLION)
        • Table SPAIN: BRACHYTHERAPY ISOTOPES MARKET, BY TYPE, 2016–2023 (USD MILLION)
        • Table SPAIN: THERAPEUTIC NUCLEAR MEDICINE MARKET, BY APPLICATION, 2016–2023 (USD MILLION)
      • ROE
        • Table ROE: NUCLEAR MEDICINE MARKET, BY TYPE, 2016–2023 (USD MILLION)
        • Table ROE: DIAGNOSTIC NUCLEAR MEDICINE MARKET, BY TYPE, 2016–2023 (USD MILLION)
        • Table ROE: SPECT RADIOPHARMACEUTICALS MARKET, BY TYPE, 2016–2023 (USD MILLION)
        • Table ROE: SPECT RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2016–2023 (USD MILLION)
        • Table ROE: PET RADIOPHARMACEUTICALS MARKET, BY TYPE, 2016–2023 (USD MILLION)
        • Table ROE: PET RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2016–2023 (USD MILLION)
        • Table ROE: THERAPEUTIC NUCLEAR MEDICINE MARKET, BY TYPE, 2016–2023 (USD MILLION)
        • Table ROE: BETA EMITTERS MARKET, BY TYPE, 2016–2023 (USD MILLION)
        • Table ROE: BRACHYTHERAPY ISOTOPES MARKET, BY TYPE, 2016–2023 (USD MILLION)
        • Table ROE: THERAPEUTIC NUCLEAR MEDICINE MARKET, BY APPLICATION, 2016–2023 (USD MILLION)
    • ASIA PACIFIC
      • Table ASIA PACIFIC: NUCLEAR MEDICINE MARKET, BY TYPE, 2016–2023 (USD MILLION)
      • Table ASIA PACIFIC: DIAGNOSTIC NUCLEAR MEDICINE MARKET, BY TYPE, 2016–2023 (USD MILLION)
      • Table ASIA PACIFIC: SPECT RADIOPHARMACEUTICALS MARKET, BY TYPE, 2016–2023 (USD MILLION)
      • Table ASIA PACIFIC: SPECT RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2016–2023 (USD MILLION)
      • Table ASIA PACIFIC: PET RADIOPHARMACEUTICALS MARKET, BY TYPE, 2016–2023 (USD MILLION)
      • Table ASIA PACIFIC: PET RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2016–2023 (USD MILLION)
      • Table ASIA PACIFIC: THERAPEUTIC NUCLEAR MEDICINE MARKET, BY TYPE, 2016–2023 (USD MILLION)
      • Table ASIA PACIFIC: BETA EMITTERS MARKET, BY TYPE, 2016–2023 (USD MILLION)
      • Table ASIA PACIFIC: BRACHYTHERAPY ISOTOPES MARKET, BY TYPE, 2016–2023 (USD MILLION)
      • Table ASIA PACIFIC: THERAPEUTIC NUCLEAR MEDICINE MARKET, BY APPLICATION, 2016–2023 (USD MILLION)
    • REST OF THE WORLD
      • Table ROW: NUCLEAR MEDICINE MARKET, BY TYPE, 2016–2023 (USD MILLION)
      • Table ROW: DIAGNOSTIC NUCLEAR MEDICINE MARKET, BY TYPE, 2016–2023 (USD MILLION)
      • Table ROW: SPECT RADIOPHARMACEUTICALS MARKET, BY TYPE, 2016–2023 (USD MILLION)
      • Table ROW: SPECT RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2016–2023 (USD MILLION)
      • Table ROW: PET RADIOPHARMACEUTICALS MARKET, BY TYPE, 2016–2023 (USD MILLION)
      • Table ROW: PET RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2016–2023 (USD MILLION)
      • Table ROW: THERAPEUTIC NUCLEAR MEDICINE MARKET, BY TYPE, 2016–2023 (USD MILLION)
      • Table ROW: BETA EMITTERS MARKET, BY TYPE, 2016–2023 (USD MILLION)
      • Table ROW: BRACHYTHERAPY ISOTOPES MARKET, BY TYPE, 2016–2023 (USD MILLION)
      • Table ROW: THERAPEUTIC NUCLEAR MEDICINE MARKET, BY APPLICATION, 2016–2023 (USD MILLION)
  • COMPETITIVE LANDSCAPE
    • OVERVIEW
    • MARKET SHARE ANALYSIS
    • COMPETITIVE SCENARIO
      • AGREEMENTS, PARTNERSHIPS, AND CONTRACTS
        • Table AGREEMENTS, PARTNERSHIPS, AND CONTRACTS (2015–2018)
      • PRODUCT APPROVALS
        • Table PRODUCT APPROVALS (2015–2018)
      • FUNDING
        • Table FUNDING (2015–2018)
      • ACQUISITIONS
        • Table ACQUISITIONS (2015–2018)
      • EXPANSIONS
        • Table EXPANSIONS (2015–2018)
      • OTHER DEVELOPMENTS
        • Table OTHER DEVELOPMENTS (2015–2018)
  • COMPANY PROFILES
    • CARDINAL HEALTH
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
      • SWOT ANALYSIS
      • MNM VIEW
    • GE HEALTHCARE (A FULLY-OWNED SUBSIDIARY OF GENERAL ELECTRIC COMPANY)
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
      • SWOT ANALYSIS
      • MNM VIEW
    • CURIUM
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
      • SWOT ANALYSIS
      • MNM VIEW
    • LANTHEUS MEDICAL IMAGING
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • BAYER
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • BRACCO IMAGING
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • MNM VIEW
    • ECZACIBASI-MONROL NUCLEAR PRODUCTS
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • NORDION (A SUBSIDIARY OF STERIGENICS INTERNATIONAL)
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • ADVANCED ACCELERATOR APPLICATIONS (AAA, ACQUIRED BY NOVARTIS)
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
      • MNM VIEW
  • APPENDIX
    • DISCUSSION GUIDE
    • INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
    • AVAILABLE CUSTOMIZATIONS
    • RELATED REPORTS
    • AUTHOR DETAILS

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report